The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

Japan to Compensate Patients Who Contracted Hepatitis C From Tainted Blood Products

January 11, 2008

On Friday, Japan's upper house in the Diet unanimously passed a bill to apologize and compensate patients who were infected with hepatitis C through contaminated blood products.

The victims say the government continued to approve the use of the blood-clotting agent fibrinogen for years after 1977, when the United States discontinued using it due to its risks. Before its use was suspended, the product was tied in reports to outbreaks of hepatitis C in Japan as early as the mid-1980s. It is also thought the risks were well-known in medical circles.

"I offer my heartfelt apologies to the patients and their bereaved families," Prime Minister Yasuo Fukada said in a statement after the vote. The lower house passed the measure earlier in the week.

Under the law, which is expected to take effect next week, about 1,000 people with hepatitis C will receive compensation ranging from ¥12 million to ¥40 million (US $109,450-$365,000), depending on the severity of their condition, according to the Health Ministry.

The law directs the government to call on drug makers Nihon Pharmaceutical Co., Mitsubishi Tanabe Pharma and its subsidiary Benesis Corp. to contribute to the victims' compensation fund.

Back to other news for January 2008

Adapted from:
Associated Press
01.11.2008, Chisaki Watanabe

  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
See Also
More HIV News
Find out how a Walgreens specially trained pharmacist can help you